Search

Mark L. Berch

Examiner (ID: 99)

Most Active Art Unit
1202
Art Unit(s)
1202, 1624, 1622, 1802, 2899, 1614, 1611
Total Applications
3573
Issued Applications
2301
Pending Applications
170
Abandoned Applications
1103

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5237177 [patent_doc_number] => 20070129334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'Orally Active Purine-Based Inhibitors of Heat Shock Protein 90' [patent_app_type] => utility [patent_app_number] => 11/612418 [patent_app_country] => US [patent_app_date] => 2006-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 64275 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20070129334.pdf [firstpage_image] =>[orig_patent_app_number] => 11612418 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/612418
Orally Active Purine-Based Inhibitors of Heat Shock Protein 90 Dec 17, 2006 Abandoned
Array ( [id] => 8177640 [patent_doc_number] => 08178665 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-15 [patent_title] => 'Process for the production of ezetimibe and intermediates used in this process' [patent_app_type] => utility [patent_app_number] => 12/097185 [patent_app_country] => US [patent_app_date] => 2006-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6991 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/178/08178665.pdf [firstpage_image] =>[orig_patent_app_number] => 12097185 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/097185
Process for the production of ezetimibe and intermediates used in this process Dec 17, 2006 Issued
Array ( [id] => 5310867 [patent_doc_number] => 20090018148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'Xanthine Derivatives, Processes For Preparing Them And Their Uses' [patent_app_type] => utility [patent_app_number] => 12/096340 [patent_app_country] => US [patent_app_date] => 2006-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12870 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20090018148.pdf [firstpage_image] =>[orig_patent_app_number] => 12096340 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/096340
Xanthine Derivatives, Processes For Preparing Them And Their Uses Nov 29, 2006 Abandoned
Array ( [id] => 356381 [patent_doc_number] => 07488818 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-10 [patent_title] => 'Method for producing 1,4-diphenyl azetidinone derivatives' [patent_app_type] => utility [patent_app_number] => 11/561626 [patent_app_country] => US [patent_app_date] => 2006-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8204 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/488/07488818.pdf [firstpage_image] =>[orig_patent_app_number] => 11561626 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/561626
Method for producing 1,4-diphenyl azetidinone derivatives Nov 19, 2006 Issued
Array ( [id] => 4899882 [patent_doc_number] => 20080119496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => '7-Substituted Purine Derivatives for Immunosuppression' [patent_app_type] => utility [patent_app_number] => 11/560731 [patent_app_country] => US [patent_app_date] => 2006-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26648 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20080119496.pdf [firstpage_image] =>[orig_patent_app_number] => 11560731 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/560731
7-Substituted Purine Derivatives for Immunosuppression Nov 15, 2006 Abandoned
Array ( [id] => 4972190 [patent_doc_number] => 20070112193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'VALACYCLOVIR PROCESS' [patent_app_type] => utility [patent_app_number] => 11/559427 [patent_app_country] => US [patent_app_date] => 2006-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7236 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20070112193.pdf [firstpage_image] =>[orig_patent_app_number] => 11559427 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/559427
VALACYCLOVIR PROCESS Nov 13, 2006 Abandoned
Array ( [id] => 5057640 [patent_doc_number] => 20070060562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Novel crystal form of pyrrolidylthiocarbapenem derivative' [patent_app_type] => utility [patent_app_number] => 11/595348 [patent_app_country] => US [patent_app_date] => 2006-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4715 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20070060562.pdf [firstpage_image] =>[orig_patent_app_number] => 11595348 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/595348
Novel crystal form of pyrrolidylthiocarbapenem derivative Nov 9, 2006 Abandoned
Array ( [id] => 270652 [patent_doc_number] => 07563888 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-21 [patent_title] => 'Process for the preparation of diphenyl azetidinone derivatives' [patent_app_type] => utility [patent_app_number] => 11/557310 [patent_app_country] => US [patent_app_date] => 2006-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24573 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/563/07563888.pdf [firstpage_image] =>[orig_patent_app_number] => 11557310 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/557310
Process for the preparation of diphenyl azetidinone derivatives Nov 6, 2006 Issued
Array ( [id] => 5070229 [patent_doc_number] => 20070191331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Crystalline forms of cefdinir potassium salt' [patent_app_type] => utility [patent_app_number] => 11/591217 [patent_app_country] => US [patent_app_date] => 2006-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9221 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191331.pdf [firstpage_image] =>[orig_patent_app_number] => 11591217 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/591217
Crystalline forms of cefdinir potassium salt Oct 30, 2006 Abandoned
Array ( [id] => 5248081 [patent_doc_number] => 20070244315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Process for the preparation of cefdinir' [patent_app_type] => utility [patent_app_number] => 11/591246 [patent_app_country] => US [patent_app_date] => 2006-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3997 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20070244315.pdf [firstpage_image] =>[orig_patent_app_number] => 11591246 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/591246
Process for the preparation of cefdinir Oct 30, 2006 Abandoned
Array ( [id] => 5576212 [patent_doc_number] => 20090143574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Carbapenem Compound' [patent_app_type] => utility [patent_app_number] => 12/084351 [patent_app_country] => US [patent_app_date] => 2006-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3302 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143574.pdf [firstpage_image] =>[orig_patent_app_number] => 12084351 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/084351
Carbapenem compound Oct 30, 2006 Issued
Array ( [id] => 5070500 [patent_doc_number] => 20070191602 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Crystalline form of cefdinir cesium salt' [patent_app_type] => utility [patent_app_number] => 11/593261 [patent_app_country] => US [patent_app_date] => 2006-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5149 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191602.pdf [firstpage_image] =>[orig_patent_app_number] => 11593261 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/593261
Crystalline form of cefdinir cesium salt Oct 30, 2006 Abandoned
Array ( [id] => 5041229 [patent_doc_number] => 20070093511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Anhydrous Crystal Form of Valaciclovir Hydrochloride' [patent_app_type] => utility [patent_app_number] => 11/552218 [patent_app_country] => US [patent_app_date] => 2006-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10548 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20070093511.pdf [firstpage_image] =>[orig_patent_app_number] => 11552218 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/552218
Anhydrous Crystal Form of Valaciclovir Hydrochloride Oct 23, 2006 Abandoned
Array ( [id] => 5154903 [patent_doc_number] => 20070037786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Cephem compounds' [patent_app_type] => utility [patent_app_number] => 11/585262 [patent_app_country] => US [patent_app_date] => 2006-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39191 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20070037786.pdf [firstpage_image] =>[orig_patent_app_number] => 11585262 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/585262
Cephem compounds Oct 23, 2006 Abandoned
Array ( [id] => 5154949 [patent_doc_number] => 20070037832 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Novel adenine derivatives' [patent_app_type] => utility [patent_app_number] => 11/582452 [patent_app_country] => US [patent_app_date] => 2006-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 48496 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20070037832.pdf [firstpage_image] =>[orig_patent_app_number] => 11582452 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/582452
Adenine derivatives Oct 17, 2006 Issued
Array ( [id] => 5429256 [patent_doc_number] => 20090088566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-02 [patent_title] => 'Usage of Poly-3-Hydroxybutyrates in Preparation of Beta-Lactam Compounds' [patent_app_type] => utility [patent_app_number] => 12/280781 [patent_app_country] => US [patent_app_date] => 2006-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2017 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20090088566.pdf [firstpage_image] =>[orig_patent_app_number] => 12280781 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/280781
Usage of poly-3-hydroxybutyrates in preparation of β-lactam compounds Oct 15, 2006 Issued
Array ( [id] => 4698892 [patent_doc_number] => 20080221076 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'Crystalline Sodium Salt of Cephalosporin Antibiotic' [patent_app_type] => utility [patent_app_number] => 12/089821 [patent_app_country] => US [patent_app_date] => 2006-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4659 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20080221076.pdf [firstpage_image] =>[orig_patent_app_number] => 12089821 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/089821
Crystalline sodium salt of cephalosporin antibiotic Oct 11, 2006 Issued
Array ( [id] => 5154904 [patent_doc_number] => 20070037787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use' [patent_app_type] => utility [patent_app_number] => 11/544746 [patent_app_country] => US [patent_app_date] => 2006-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11871 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20070037787.pdf [firstpage_image] =>[orig_patent_app_number] => 11544746 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/544746
Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use Oct 9, 2006 Issued
Array ( [id] => 5000383 [patent_doc_number] => 20070043017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use' [patent_app_type] => utility [patent_app_number] => 11/544718 [patent_app_country] => US [patent_app_date] => 2006-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11919 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20070043017.pdf [firstpage_image] =>[orig_patent_app_number] => 11544718 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/544718
Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use Oct 9, 2006 Issued
Array ( [id] => 5291185 [patent_doc_number] => 20090023915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Process for the Preparation of Faropenem' [patent_app_type] => utility [patent_app_number] => 12/089159 [patent_app_country] => US [patent_app_date] => 2006-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 974 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023915.pdf [firstpage_image] =>[orig_patent_app_number] => 12089159 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/089159
Process for the preparation of faropenem Oct 4, 2006 Issued
Menu